Your browser doesn't support javascript.
loading
Pericytes augment glioblastoma cell resistance to temozolomide through CCL5-CCR5 paracrine signaling.
Zhang, Xiao-Ning; Yang, Kai-Di; Chen, Cong; He, Zhi-Cheng; Wang, Qiang-Hu; Feng, Hua; Lv, Sheng-Qing; Wang, Yan; Mao, Min; Liu, Qing; Tan, Yao-Yao; Wang, Wen-Ying; Li, Tian-Ran; Che, Lin-Rong; Qin, Zhong-Yi; Wu, Ling-Xiang; Luo, Min; Luo, Chun-Hua; Liu, Yu-Qi; Yin, Wen; Wang, Chao; Guo, Hai-Tao; Li, Qing-Rui; Wang, Bin; Chen, Wei; Wang, Shuang; Shi, Yu; Bian, Xiu-Wu; Ping, Yi-Fang.
Afiliação
  • Zhang XN; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Yang KD; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Chen C; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • He ZC; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Wang QH; Department of Bioinformatics, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Feng H; Department of Neurosurgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Lv SQ; Department of Neurosurgery, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Wang Y; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Mao M; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Liu Q; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Tan YY; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Wang WY; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Li TR; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Che LR; Department of Gastroenterology, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Qin ZY; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Wu LX; Department of Gastroenterology, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Luo M; Department of Bioinformatics, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Luo CH; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Liu YQ; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Yin W; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Wang C; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Guo HT; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Li QR; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Wang B; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Chen W; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Wang S; Department of Gastroenterology, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Shi Y; Department of Radiology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Bian XW; Department of Radiology, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Ping YF; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China. drshiyu@126.com.
Cell Res ; 31(10): 1072-1087, 2021 10.
Article em En | MEDLINE | ID: mdl-34239070
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma Idioma: En Ano de publicação: 2021 Tipo de documento: Article